The landscape of myeloid and astrocyte phenotypes in acute multiple sclerosis lesions by Park, Calvin et al.
RESEARCH Open Access
The landscape of myeloid and astrocyte
phenotypes in acute multiple sclerosis
lesions
Calvin Park1, Gerald Ponath1, Maya Levine-Ritterman1, Edward Bull1, Eric C. Swanson2, Philip L. De Jager3,
Benjamin M. Segal4 and David Pitt1*
Abstract
Activated myeloid cells and astrocytes are the predominant cell types in active multiple sclerosis (MS) lesions. Both
cell types can adopt diverse functional states that play critical roles in lesion formation and resolution. In order to
identify phenotypic subsets of myeloid cells and astrocytes, we profiled two active MS lesions with thirteen glial
activation markers using imaging mass cytometry (IMC), a method for multiplexed labeling of histological sections.
In the acutely demyelinating lesion, we found multiple distinct myeloid and astrocyte phenotypes that populated
separate lesion zones. In the post-demyelinating lesion, phenotypes were less distinct and more uniformly
distributed. In both lesions cell-to-cell interactions were not random, but occurred between specific glial
subpopulations and lymphocytes. Finally, we demonstrated that myeloid, but not astrocyte phenotypes were
activated along a lesion rim-to-center gradient, and that marker expression in glial cells at the lesion rim was driven
more by cell-extrinsic factors than in cells at the center. This proof-of-concept study demonstrates that highly
multiplexed tissue imaging, combined with the appropriate computational tools, is a powerful approach to study
heterogeneity, spatial distribution and cellular interactions in the context of MS lesions. Identifying glial phenotypes
and their interactions at different lesion stages may provide novel therapeutic targets for inhibiting acute
demyelination and low-grade, chronic inflammation.
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Introduction
Multiple sclerosis (MS) is a common neurological dis-
ease, characterized by the formation of inflammatory
demyelinating lesions in the central nervous system
(CNS) [26]. Inflammation is driven by infiltrating
lymphocytes and monocytes, in concert with resident
activated microglia and astrocytes. Macrophages and
reactive astrocytes are the most abundant cell types
in acute lesions [18, 30]. These cells are highly plastic
and can adopt pro-inflammatory, anti-inflammatory,
neurotoxic, neuroprotective, and tissue-regenerating
functions [4, 6, 7, 20, 23, 29, 30, 42]. Previous studies
have identified macrophage phenotypes in MS lesions
based on the expression of single classical (M1) and
alternative (M2) activation markers; however, those
studies have produced limited and sometimes conflict-
ing results [6, 42]. It is now increasingly clear that
the M1/M2 polarization paradigm, which originated
as an in vitro concept, is of limited value for distin-
guishing myeloid phenotypes in inflamed tissue [35].
Recent studies, including one of our own, have used
single-cell or single-nucleus RNA sequencing on CNS
tissue to comprehensively assess the complex pheno-
types of human glial cells in healthy and diseased
brains [14, 22, 27]. Similarly, in these studies, myeloid
cell/microglial phenotypes did not separate into categor-
ies in which M1 and M2 markers are of organizational
value.
Several novel histological techniques now make it pos-
sible to perform high parameter imaging of tissue sections
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and to evaluate complex cellular phenotypes in situ
[5, 8, 9, 11, 41]. We have used imaging mass cytome-
try (IMC), a technique that like mass cytometry (CyTOF)
relies on metal isotope-labeled antibodies, and combines
immunohistochemistry with high-resolution laser ablation
followed by time-of-flight mass spectrometry [9, 43]. This
approach allows for simultaneous quantitative profiling
with up to 37 antibodies on a single tissue section at sub-
cellular resolution. Moreover, computational tools have
become available to extract single-cell information from
highly multiplexed histological data [3, 24, 36]. In this
proof-of-concept study, we applied IMC and single-cell
analytics to two active MS lesions – one demyelinating
and one post-demyelinating – to examine the cellular het-
erogeneity of myeloid cells and astrocytes based on thir-
teen markers known to be expressed by activated glial
cells in MS lesions [2, 6, 13, 15, 31, 42, 44, 45]. We dem-
onstrate that multiplexed tissue imaging, in combination
with the appropriate computational tools, can extract
previously unattainable information from histological
sections, including definition of cellular subpopulations,
their distribution within the lesion environment, specific
cell-cell interactions, phenotypic transitions and the im-
pact of spatial sources on marker expression.
Materials and methods
MS lesions
Human CNS tissue was obtained at autopsy from two
patients with relapsing-remitting MS according to insti-
tutional review board-approved protocols. After autopsy,
brain tissue was fixed in 10% formalin, and lesions were
cut based on MRI. Lesion tissue was subsequently em-
bedded in paraffin and sectioned at 5 μm thickness.
A highly inflamed active lesion was chosen for ana-
lysis from each patient: the demyelinating lesion was
selected from a 42-year-old male with 5 years disease
duration (5.5 h post mortem interval), while the post-
demyelinating lesion was chosen from a 32-year-old
female with 6 years disease duration (8 h post mortem
interval). Lesions from both patients have been char-
acterized in previous studies [10, 28].
Brightfield histology
For basic characterization, lesions were stained against
CD68, myelin basic protein (MBP) and MAP2, and ex-
amined via brightfield microscopy. De-paraffinized and
rehydrated sections were subjected to antigen retrieval
in pH 6, 10 mM citrate buffer at 96 °C for 20 min, cooled,
quenched in 0.3% peroxide, and blocked with FC recep-
tor binding inhibitor and normal serum before incuba-
tion with primary antibody (Additional file 1: Table S1)
overnight at 4 °C. Sections were subsequently incubated
with appropriate biotinylated secondary antibodies,
processed with an avidin/biotin staining kit with 3,3-
diaminobenzidene (DAB) as the chromogen (Vector
ABC Elite Kit and DAB Kit, Vector Laboratories), then
counterstained with hematoxylin [28]. Adequate controls
using isotype control antibodies were performed for each
primary antibody. Sections were rinsed with distilled
water, dehydrated, and cover-slipped with Permount
(Vector Laboratories). Images were acquired using a
Leica DM5000 B microscope with a Leica color camera
DFC310 Fx and Leica Application Suite (version 4.9.0)
imaging software. Images were processed with Panoramic
Viewer (3DHISTECH) and Photoshop (Adobe) software.
Antibody validation and conjugation to metal isotopes
for IMC
Lanthanide-conjugated antibodies were purchased from
Fluidigm. Antibodies not available in metal-conjugated
form were purchased in carrier-free solution and validated
by brightfield immunohistochemistry using the appropri-
ate isotype control antibodies. Subsequently, antibodies
were conjugated to lanthanide metal isotopes following
the Maxpar® Antibody Labeling Kit protocol (Fluidigm).
Briefly, carrier-free antibodies were partially reduced with
Bond-Breaker™ TCEP buffer (Thermo Scientific) at 37 °C
before incubation with purified, lanthanide-loaded Max-
par® X8 polymer at 37 °C for 90min. The percent yield of
metal-conjugated antibodies was determined using the
Pierce™ BCA Protein Assay Kit (Thermo Scientific).
Metal-conjugated antibodies were stored at 0.5mg/mL in
PBS-based Antibody Stabilizer (Candor Bioscience) with
0.05% sodium azide at 4 °C. Working concentrations for
all metal-conjugated antibodies were optimized by IMC
(Additional file 1: Table S2) on MS lesion tissue.
Imaging mass cytometry
For IMC histology, tissue sections were de-paraffinized
and rehydrated, and antigen retrieval was performed in
pH 8, 1mM EDTA buffer at 96 °C for 20min. Sections
were cooled at room temperature and rinsed in tap water
and TBS (20mM Tris with 500mM NaCl, pH 7.5). Tissue
was blocked for 3 h at room temperature with 0.3% BSA,
25% FBS and 0.1mg/mL FC receptor binding inhibitor in
TBS-T (TBS + 0.05% Tween-20). All antibodies (Add-
itional file 1: Table S2) were diluted in 0.3% BSA in TBS-T
and applied to the tissue for overnight incubation at 4 °C.
Sections were then rinsed in TBS-T and TBS, and coun-
terstained with 125 nM Maxpar® Intercalator-Ir (Fluidigm)
in PBS for 1 h at room temperature. Sections were rinsed
in TBS-T, TBS, and two washes of distilled water before
air-drying at room temperature. Antibody-labeled tissue
areas (1000 × 1000 μm) were raster-ablated using a
Hyperion™ Laser Scanning Module (Fluidigm) with a 1 μm
diameter spot size at 200 Hz. This process was coupled to
a Helios™ Mass Cytometer (Fluidigm) for lanthanide metal
detection [43]. Images for each antibody channel were
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acquired on CyTOF Software (Fluidigm, version 6.7).
MCD Viewer (Fluidigm, version 1.0) was used to export
raw 16-bit tiff images for computational analyses on histo-
CAT (version 1.75) [36]. For visualization purposes,
images were processed in MCD Viewer and ImageJ [38].
Computational analyses
Single-cell segmentation
Merged CD68 (macrophages/microglia), S100B (astro-
cytes), and CD3 (T cells) antibody channel images were
first processed on MCD Viewer and ImageJ to diminish
unspecific staining noise that could interfere with seg-
mentation. These image adjustments helped distinguish
closely neighboring CD68, S100B and CD3 cell bodies
from one another. The resulting images served as the
staining template to segment single cell objects on Cell-
Profiler (version 3.0.0) [16]. The IdentifyPrimaryObjects
module was used for segmentation with three-class
Adaptive Otsu thresholding, shape or signal intensity-
based declumping, and the propagation method for
drawing dividing lines between clumped cell objects.
The typical object diameter was assigned based on the
approximate range of cell sizes present in an image. For
three-class thresholding, the middle class was assigned
to either foreground or background based on the inten-
sity of residual noise in an image. These optimal param-
eters were determined based on the following criteria:
each segmented cell had one nucleus associated with it,
the complex morphology of CD68+ myeloid cells and
S100B+ astrocytes were reflected in the cell outlines, and
co-segmentation of the different cell type markers was
minimized to the highest extent possible. Fulfillment of
these requirements was checked by visualizing the seg-
mentation masks over merged CD68, S100B, CD3 and
nuclear counterstain images on histoCAT. Moreover,
perivascular CD68+ and CD3+ cells in the early lesion
were too densely packed to separate them by segmenta-
tion, and were eliminated in CellProfiler with the
EditObjectsManually module. The resulting segmenta-
tion mask images with outlined cell borders were
exported from CellProfiler as 16-bit unsigned integer
(uint16) images and loaded into histoCAT with corre-
sponding IMC antibody channel images.
Identification of cellular phenotypes
On histoCAT, mean single-cell marker intensity values
were extracted via segmentation masks from raw, 16-bit
tiff images for each antibody channel and Z-score nor-
malized per marker. Based on the expression intensities
of thirteen markers (Additional file 1: Table S2), cell
clusters were defined using the PhenoGraph algorithm
[19] integrated into histoCAT. Default parameters with
75 nearest neighbors for the early lesion and 50 nearest
neighbors for the late lesion were used. These nearest
neighbor values were chosen such that over- and under-
clustering of phenotypes were avoided. Additional
normalization steps were performed internally, as previ-
ously described [36].
Analysis of cellular phenotypes
To visualize clusters, the Barnes-Hut t-SNE algorithm
implemented in histoCAT was executed with the same
image and marker inputs used in PhenoGraph, as well
as default parameters (initial dimensions, 110; perplexity,
30; theta, 0.5) and internal normalization [1, 36]. t-SNE
plots were colored to highlight cell clusters or lesion
samples, or to show relative marker expression intensity.
Images of cell phenotypes visualized in the tissue, as well
as segmentation masks overlaid with histology images,
were generated in histoCAT. For the remaining analyses,
“.csv” files containing single-cell parameters were
exported from histoCAT and appropriately processed for
their application. To produce an expression heatmap for
clusters, Z-score normalized marker intensity values
were processed using the R ComplexHeatmap package,
which hierarchically clusters single cells within clusters
using Ward’s method [37]. Violin plots showing single-
cell marker expression variability for each cluster were
generated using the R ggplot2 package [12].
To study phenotype transitions, Potential of Heat-dif-
fusion Affinity-based Transition Embedding (PHATE)
mapping and Monocle 2 Pseudotime analyses were per-
formed in R [24, 33, 34, 40]. For these analyses, files
containing single-cell marker expression values along
with metadata files indexing the phenotype of each cell
served as input, as detailed in the online user guides.
Moreover, relevant markers were selected for analyses
of myeloid cells (all markers except for CD3, S100B and
vimentin) or astrocytes (all markers except for CD3 and
CD68).
PHATE mapping was performed using Z-score nor-
malized marker intensity values, to be consistent with
the input used in histoCAT for cell clustering and t-
SNE plots. With this input, we tested different values
of the adjustable, nearest neighbor parameter k that is
built into the PHATE algorithm. Larger values of k
make transition states less distinct from one another,
while smaller values increase the influence of any
artefacts on the analysis [19]. Since k is a nearest
neighbor metric and large values could obscure bio-
logically meaningful transitions, we used values that
were significantly less than the number of cells ana-
lyzed, but large enough to avoid misleading results
due to noise. We found that different values of k
above 30 did not significantly change the results and
ultimately chose k = 100 for our analyses. Other
parameters were left as their default specifications.
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Monocle 2 Pseudotime analysis was performed with
internal, negative binomial normalization of raw marker
intensity values, as suggested by the user guide. A test
for differential marker expression among phenotypes
was performed as part of the analysis, generating q
values for each marker that indicated how significant
expression differences were among phenotypes. Provided
that Pseudotime was developed to accommodate full-
transcriptome datasets, this test would allow genes with
similar expression levels across phenotypes to be filtered
out based on a chosen q value threshold. We broadly set
q < 1 as the criteria for using a marker in the ordering_
genes function after reviewing the test results, to ensure
that all parameters would be used as they were in
PHATE mapping.
Figures showing phenotype cell size and quantity as
well as correlation matrices and plots were produced in
Prism (version 7). FlowJo software (version 10.5.3) was
used to visualize single-cell marker data on flow cytome-
try plots. Images and figures were recolored when neces-
sary in Photoshop.
Analysis of cell spatial relationships
To study the spatial relationships of cell clusters,
neighborhood analysis was performed on histoCAT
using the PhenoGraph-generated clusters pertaining
to each lesion. Significant pairwise phenotype interac-
tions and avoidances were determined by an unbiased
permutation test which compared the frequency of
one cell type neighboring another to the frequency in
999 random permutations of cell cluster labels.
Neighbors were identified within 4 μm of each cell,
and neighboring frequency was normalized to the
number of interacting cells [36]. Analyses were per-
formed for different degrees of significance (p < 0.05
and p < 0.01), and the results were reported on a
heatmap. To identify sources of single-cell marker
variation, spatial variance component analysis (SVCA)
[3] was performed on Python for different lesion
zones, using standardized marker intensity values and
the spatial coordinates of each cell in tissue images.
SVCA plots were generated in R and Prism.
Statistical analyses
In plots showing phenotype cell size, data represent
mean cell areas + standard deviation. Comparisons of
phenotype cell sizes were analyzed by one-way
ANOVA followed by the Tukey-Kramer multiple com-
parison test. Comparisons of two samples were
carried out by unpaired Student’s t-tests. For correl-
ation analyses, Pearson correlation coefficients were
computed. *p < 0.0001.
Results
Histology and cell clustering overview
We analyzed one demyelinating and one post-demye-
linating MS lesion according to a classification by
Kuhlmann et al. [17], referred to throughout this report
as the “early” and “late” lesion, respectively. Both le-
sions were located in the brain stem and characterized
by complete loss of myelin, hypercellularity with the
highest cellular density at the lesion rim, and diffuse in-
filtration with foamy macrophages. The laser-scanned
area of the early lesion involved predominantly white
matter (WM), but also interspersed gray matter (G/
WM), while the scanned area of the late lesion
consisted of only WM (Additional file 1: Figure S1).
Consistent with demyelinating activity, macrophages at
the rim of the early lesion contained myelin basic pro-
tein (MBP)-positive myelin debris, which was absent in
macrophages from the late lesion (Additional file 1:
Figure S1d, j) [17]. Moreover, foamy macrophages were
numerous and large in size in the rim of the early
lesion, whereas macrophages in the rim of the late l-
esion were smaller and less dense (Additional file 1:
Figure S1e, k). Perivascular infiltrates in the early lesion
contained mostly lymphocytes and only a few undiffer-
entiated monocytes, while the perivascular cuffs in the
late lesion consisted predominantly of lipid-laden
macrophages, as described previously (Additional file 1:
Figure S1i, l) [21, 39].
We immunolabeled both lesions with antibodies
against the cellular and activation markers CD68, S100B,
CD3, PLP, CD45, CD86, ferritin, HLA-DR, LAMP1,
Mac2, MerTK, TIM-3 and vimentin; all known to be
expressed in MS lesions [2, 6, 13, 15, 31, 42, 44, 45]. We
defined single cells by segmenting cell bodies outlined
by the markers CD68 (macrophages/microglia), S100B
(astrocytes), and CD3 (T cells) using CellProfiler (Fig. 1;
see Methods for a detailed description of segmentation
parameters) [16]. Our segmentation methods captured
the complex morphologies of myeloid cells and astro-
cytes, and allowed for clear delineation of cell types in
the vast majority of segmented cells. In a small fraction
of these cells, overlap between cellular markers could
not be avoided with our segmentation pipeline. This
overlap occurred between myelin fibers and juxtaposed
microglial processes in normal-appearing white matter
(NAWM), and between astrocyte processes and closely
neighboring macrophages (Fig. 1c, d). We did not ex-
clude these cells in order to avoid bias in our spatial
analysis. However, we excluded perivascular lymphocytes
from the early lesion, as they were too densely packed to
be identifiable as individual cells.
Single-cell segmentation masks were overlaid with
IMC images from all thirteen antibody channels
(Additional file 1: Figures S2, S3) in histoCAT [36] to
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extract mean single-cell marker expression intensity
values from the images, and to cluster myeloid cells
and astrocytes into phenotypic subpopulations based
on normalized expression intensities. We obtained the
optimal number of phenotype clusters, based on
separation of the principal cell types (i.e. myeloid
cells, astrocytes and T cells) and distinctive expression
profiles of phenotypes on expression heatmaps and t-
SNE plots, resulting in a total of twelve phenotypes
in each lesion (Figs. 2, 4). Given differences in their
cellular composition, this required different nearest
neighbor values for the early and late lesion (75 and
50 nearest neighbors, respectively). t-SNE plots were
generated in histoCAT with the same image and nor-
malized marker expression inputs were used to gener-
ate phenotype clusters and phenotype locations in the
tissue were automatically labeled in images following
clustering.
Phenotype heterogeneity and distribution in early
demyelination
In the early lesion, we analyzed a total of 4397 cells, of
which 66.3% were myeloid cells and 32.5% were astro-
cytes (Additional file 1: Figure S4a). This ratio was
higher at the rim than the lesion center. The cells clus-
tered into six myeloid and five astrocyte subtypes (Fig. 2).
Fig. 1 Single-cell segmentation. (a-c) Segmentation of myeloid cells (CD68, magenta), astrocytes (S100B, green) and T cells (CD3, cyan)
performed on CellProfiler. (b) shows cells in (a) at higher magnification. (c) shows examples of S100B+ astrocyte processes (white arrows)
that closely neighbor CD68+ cells, which resulted in the co-segmentation of these markers in a small fraction of cells. (d) Gating of
CD68+ and S100B+ populations on a flow cytometry plot as a quality control for segmentation (late lesion). The overlap population
consists of cells with co-segmented CD68 and S100B like those in (c). Scale bar in (a) = 30 μm; (b)= 15 μm; (c)= 30 μm, inset = 10 μm. Z-score
normalized expression intensities are shown (d)
Fig. 2 Early lesion cell phenotype profiles. (a) Marker expression heatmap for the myeloid, astrocyte and T cell phenotypes, identified by
PhenoGraph clustering on histoCAT using segmented cells (n = 4397). The heatmap displays relative expression levels based on Z-score
normalized marker intensity values, and single cells are hierarchically clustered within each phenotype group. Labels at the bottom of the
heatmap indicate the area of the lesion to which each phenotype localizes. (b) Violin plot representation of the data in (a). (c) t-SNE plot
showing the distinct phenotype clusters. (d) t-SNE plot colored by marker intensity, confirming the separation of CD68+, S100B+ and CD3+ cell
types. G/WMoR = gray and white matter outer rim; WMoR = white matter outer rim; iR = inner rim; WM R/C = white matter rim/center; C = center;
NAWM= normal-appearing white matter
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The myeloid phenotypes were spatially sequestered into
four lesional regions, i.e. lesion center (phenotypes m2
and 4), inner lesion rim (m3), outer lesion rim (m1 and
5) and NAWM (m6) (Fig. 3a). Most myeloid cell activa-
tion markers were highly expressed in the outer lesion
rim and decreased in intensity towards the lesion center
(Fig. 2a, b). The m1 phenotype at the G/WM interface
showed the highest activation profile. m5 cells in the
outer WM rim were the largest in size, whereas m2 cells
in the lesion center were the smallest (Additional file 1:
Figure S4b), which may reflect the amount of myelin
fragments phagocytosed by foamy macrophages at the
Fig. 3 Early lesion phenotype spatial distributions and transition analyses. (a, b) Spatial separation of (a) myeloid cell and (b) astrocyte
phenotypes into NAWM, rim and center lesion zones. (c) T cells are primarily located in the lesion center. (d) PHATE mapping of myeloid cells,
indicating that the G/WM outer rim (m1) and lesion center phenotypes (m2) are on a transition continuum (white arrow). (e) Pseudotime analysis
of myeloid cells shows that phenotypes transition along independent trajectories. Phenotype color schemes on the PHATE and Pseudotime plots
reflect the color palettes specific to each analysis. Scale bar for a-c = 200 μm. G/WMoR = gray and white matter outer rim; WMoR = white matter
outer rim; iR = inner rim; WM R/C = white matter rim/center; C = center; NAWM= normal-appearing white matter
Park et al. Acta Neuropathologica Communications           (2019) 7:130 Page 6 of 13
advancing lesion edge, and the degradation of myelin in
phagocytes within the lesion center [32].
Astrocyte phenotypes were each defined by one dis-
tinct, highly expressed marker (Fig. 2a, b). Analogous to
the myeloid phenotypes, the five astrocyte phenotypes
were also spatially stratified into the NAWM, lesion rim,
and lesion center (Fig. 3b). Furthermore, a5 astrocytes
located in the outer rim within WM were larger than all
other phenotypes (Additional file 1: Figure S4b). Unlike
in myeloid cells, marker expression in astrocyte pheno-
types did not follow a gradient from the rim to the
lesion center, but was uniform throughout the lesion. T
cells made up the smallest population of all immune in-
filtrates, and were concentrated within the lesion center
(Fig. 3c; Additional file 1: Figure S4a). These cells uni-
formly expressed CD45 and HLA-DR (Fig. 2a, b), and
did not separate into different clusters.
To determine possible transitions between phenotypes,
we applied Potential of Heat-diffusion Affinity-based
Transition Embedding (PHATE) mapping and Monocle
2 Pseudotime (referred to as Pseudotime) to the myeloid
cell and astrocyte populations. PHATE mapping im-
proves on t-SNE by visualizing phenotype transitions
based on differential marker expression, where smooth
continua from one phenotype to another indicate a tran-
sition trajectory [24]. Pseudotime creates a trajectory
graph by computing a minimum spanning tree onto
which the cells are projected [24, 40]. PHATE mapping
of myeloid cells showed a linear transition continuum
from the G/WM to the WM outer rim phenotypes (m1
and m5) and the lesion center phenotype (m2). (Fig. 3d).
This transition did not include the inner rim phenotype
(m3). Pseudotemporal ordering of myeloid cells with
Pseudotime did not result in a linear transition trajectory
of myeloid phenotypes but suggested several independ-
ent fates (Fig. 3e). Similarly, PHATE mapping and
Pseudotime analysis of astrocyte phenotypes indicated
independent phenotypic fates that did not transition into
one another (Additional file 1: Figure S5a, b).
Low phenotype heterogeneity and random phenotype
distributions in the late demyelinating lesion
In the late, post-demyelinating lesion we analyzed 6698
cells, with myeloid cells far outnumbering astrocytes
(91.1% myeloid cells; Additional file 1: Figure S6a), par-
ticularly at the lesion rim. The same clustering criteria
used for the early lesion resulted in nine myeloid pheno-
types and two astrocyte phenotypes in this late lesion
(Fig. 4). Myeloid phenotypes separated into lesion rim
(m3), perivascular space (m4), and NAWM (m7) zones
(Fig. 5a). In contrast to the early lesion, the six other
myeloid phenotypes were intermixed throughout the le-
sion center. These phenotypes showed a low degree of
separation on the t-SNE plot, indicating similar marker
expression profiles (Fig. 4c). The phenotypes in the
lesion rim and the perivascular space (m3, m4) were
characterized by high expression of the majority of markers,
and shared a similar expression profile with the G/WM rim
phenotype in the early lesion (m1) (Fig. 4a, b). As in the
early lesion, myeloid phenotypes in the lesion rim (m3) and
perivascular space (m4) were significantly larger than those
in the lesion center (Additional file 1: Figure S6b), but
were overall smaller than in the early lesion (Additional
file 1: Fig. S6c). Astrocytes were clustered into two
Fig. 4 Late lesion cell phenotype profiles. (a) Marker expression heatmap for the myeloid, astrocyte and T cell phenotypes, identified by PhenoGraph
clustering on histoCAT using segmented cells (n = 6698). The heatmap displays relative expression levels based on Z-score normalized marker intensity
values, and single cells are hierarchically clustered within each phenotype group. Labels at the bottom of the heatmap indicate the area of the lesion
to which each phenotype localizes. (b) Violin plot representation of the data in (a). (c) t-SNE plot showing the phenotype clusters. Compared to the
early lesion, myeloid cell phenotypes show a low degree of separation. (d) t-SNE plot colored by marker intensity, confirming the separation of CD68+,
S100B+ and CD3+ cell types. R = rim; C = center; PVS = perivascular space; NAWM= normal-appearing white matter
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phenotypes, with one phenotype localizing primarily
to the lesion rim, and the other to the lesion center
(Fig. 5b). The rim phenotype (a2) exhibited a marker
expression profile similar to the rim phenotype in the
early lesion (a5), (Fig. 4a, b). Finally, as in the early
lesions, T cells were few (Fig. 5c; Additional file 1:
Figure S6a), and expressed the activation markers
CD45 and HLA-DR (Fig. 4a, b). To directly compare cell
populations in both lesions, we mapped cells from both le-
sions on the same t-SNE plot. Cell populations overlapped
moderately, highlighting differences between the pheno-
types in each lesion (Additional file 1: Figure S7).
PHATE mapping demonstrated a linear transition con-
tinuum between two lesion center myeloid phenotypes
Fig. 5 Late lesion phenotype spatial distributions and transition analyses. (a) Spatial organization of myeloid cell phenotypes in the lesion.
Phenotypes in the rim (m3), perivascular space (m4) and NAWM (m7) separate into distinct zones, while lesion center phenotypes (m1, m2, m5,
m6, m8, m9) are uniformly distributed. (b) Spatial distribution of astrocyte phenotypes. One phenotype (a1) predominantly occupies the lesion
center and the other (a2) occupies the rim. (c) T cells are primarily distributed in the lesion center. (d) PHATE mapping of myeloid cells, showing
that two lesion center phenotypes (m2, m6) are on a continuum with perivascular space cells (m4, white arrows). (e) Pseudotime analysis of
myeloid cells shows a similar trajectory to PHATE mapping. Phenotype color schemes on the PHATE and Pseudotime plots reflect the color
palettes specific to each analysis. Scale bar for a-c = 200 μm. PVS = perivascular space; NAWM= normal-appearing white matter
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(m2, m6) and the perivascular space phenotype (m4)
(Fig. 5d), which was confirmed by Pseudotime (Fig. 5e),
supporting a lesion center-to-perivascular phenotype
trajectory, but not a continuum where all phenotypes
align along a rim-to-center transition axis. The same
analyses for astrocytes showed overlap between both
phenotypes but not a linear transition (Additional
file 1: Figure S5c, d).
Finally, in the early lesion, we found no correlation be-
tween the expression intensities of different markers at a
single-cell level (Additional file 1: Figure S8a, b). In the
late lesion, we found strong correlations between the
M2 markers MerTK and Mac2, and MerTK and LAMP1
in both myeloid cells and astrocytes (Additional file 1:
Figure S8c, d), resulting from high and continuous dy-
namic ranges of marker expression (Fig. 6).
Phenotypes in the early and late acute lesions engaged in
specific cell-cell interactions
We next investigated the spatial relationships between dif-
ferent phenotypes with a computational tool integrated
into histoCAT that performs an unbiased, systematic ana-
lysis of pairwise phenotype interactions and avoidances
[36]. After excluding interactions between cells of the
same or spatially adjacent phenotypes, our analysis dem-
onstrated distinct interaction signatures for both lesions,
(Fig. 7a, b). At a significance cut-off of p < 0.01, these in-
cluded interactions between inner rim myeloid phenotype
m3 (MerTK and CD45 high) and astrocyte phenotype a1
(Mac2 high), as well as interaction of highly activated
myeloid rim phenotype m1 and the rim/center phenotype
m4 (HLA-DR and ferritin high) with astrocyte phenotype
a2 (HLA-DR high) in the early lesion. In the late lesion,
highly activated perivascular macrophages (m4) interacted
with most myeloid cell phenotypes and both astrocyte
phenotypes. There were also significant interactions be-
tween myeloid and astrocyte phenotypes m6 and a1, and
among lesion center myeloid phenotypes (m6 with m7
and m8). At a significance cut-off of p < 0.05, we found
that T cells in the late lesion interacted with HLA-DR-ex-
pressing myeloid phenotypes in the perivascular space
(m4) and in the lesion center (m8).
Influence of lesion environment on marker expression
Finally, we used spatial variance component analysis
(SVCA) to model the effects of extrinsic factors (neigh-
boring cells and unobserved, non-cellular environmental
stimuli) and cell-intrinsic factors on variations in cell
marker expression, irrespective of phenotype [3]. This
analysis was performed for each marker, using standard-
ized single-cell marker expression values as well as the
coordinate location of each segmented cell in the tissue.
In the rim of both lesions, the expression of several
markers was highly influenced by neighboring cells, in-
cluding CD86, PLP, and Mac2 in the early lesion, and
CD86, PLP and LAMP1 in the late lesion. Other
markers, such as ferritin and vimentin (early lesion), and
ferritin, vimentin, and TIM-3 (late lesion), were driven
predominantly by non-cellular environmental stimuli
(Fig. 7c, d). The relative influence of these factors
Fig. 6 Single-cell marker correlations in the late lesion. (a, b) Co-expression of Mac2 and MerTK, and LAMP1 and MerTK in (a) myeloid
cells (n = 6100), and (b) astrocytes (n = 528). Co-expression plots are shown with linear expression values and regression lines with
Pearson correlation coefficients, and in flow cytometry contour plot form with log10-transformed expression values
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changed toward the inner lesion rim and center, leading
to an overall increased impact of cell-intrinsic factors
and a decrease in the influence of external factors. In the
lesion center, the primary agents influencing marker
expression were cell-intrinsic factors, and to a lower de-
gree environmental stimuli, while neighboring cells
exerted no influence (Fig. 7c, d).
Discussion
Our study examines the landscape of myeloid and astro-
cyte phenotypes in early and late acute MS brain lesions
using IMC. To our knowledge, this is the first applica-
tion of highly multiplexed imaging to MS tissue. We
applied thirteen markers that are known to be expressed
by activated glial cells during MS lesion development.
Clustering resulted in eleven myeloid cell and astrocyte
phenotypes that localized to distinct lesion areas. More-
over, individual phenotypes interacted selectively with
other cell types, and marker expression was driven by
different factors in cells located at the lesion rim com-
pared to the center. Thus, our approach provides a
wealth of data on cellular spatial organization that is not
accessible with standard histology.
The alignment of myeloid cell phenotypes with differ-
ent lesional layers suggests functional specificity and
validates our clustering approach. This spatial separation
was most pronounced in the early lesion, and was re-
duced in the center of the late lesion where multiple
phenotypes were intermixed. In addition, marker expres-
sion was the highest in myeloid phenotypes located at
the lesion rim and diminished substantially towards the
lesion center in both lesions. Consistent with the differ-
ent stages of myelin phagocytosis and degradation, the
myeloid phenotypes in the rim were larger than those in
the lesion center. An additional feature of the late lesion
was the presence of numerous highly activated macro-
phages in perivascular spaces throughout the lesion.
Since these macrophages are believed to transition into
the vasculature [21], this may indicate that they exit the
CNS in a highly activated state. In contrast to myeloid
cells, marker expression in astrocyte phenotypes did not
follow a rim-to-center gradient, but was consistent
throughout the lesion.
Our findings argue that macrophages/microglia in MS
lesions do not transition from a pro- to anti-inflammatory
state, as previously suggested [6], but convert from a
highly activated to a less activated state as they move from
Fig. 7 Neighborhood and spatial variance component analyses for the early and late lesions. (a, b) Neighborhood analysis heatmaps of all
significant pairwise phenotype interactions (red) and avoidances (blue) in the (a) early and (b) late lesions. White represents no significant spatial
relationship. Dark boxes are highly significant spatial relationships (p < 0.01). Lightly shaded boxes are less significant relationships (p < 0.05) and
interactions between cells of the same or spatially adjacent phenotypes. Rows visualize the significance of a phenotype surrounded by other
phenotypes, and columns visualize the significance of a phenotype surrounding other phenotypes. (c, d) Spatial variance component analysis
(SVCA) for the (c) early and (d) late lesions, showing the proportion of marker expression variance attributable to neighboring cell influences,
environmental stimuli, cell-intrinsic factors and residual noise in different lesion zones. Additional plots show the average proportion of marker
variance attributable to each factor in different lesion zones. G/WM = gray and white matter; WM =white matter; PVS = perivascular space;
NAWM= normal-appearing white matter
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the active edge to the lesion center. This is consistent with
immunohistological results by Vogel and colleagues dem-
onstrating that pro- and anti-inflammatory markers were
simultaneously expressed by macrophages/microglia in
MS lesions [42], and with single nucleus/cell RNA sequen-
cing data of microglial cells in MS and neurodegenerative
diseases, which do not produce categories related to M1
or M2 marker expression [22, 27]. Thus, our results add
to the increasing evidence that activated macrophages and
microglia in inflamed tissue do not follow a M1/M2
polarization dichotomy.
Using PHATE mapping, we found that myeloid cell
but not astrocyte phenotypes followed a linear transition
continuum from the G/WM outer rim to the WM outer
rim and the lesion center (early lesion), and from lesion
center phenotypes to the perivascular phenotype (late
lesion). In contrast, phenotype trajectories on Monocle 2
Pseudotime showed no definite transition patterns.
Although PHATE and Pseudotime provide biologically
accurate transitions when applied to data sets with com-
parable parametric depth as ours, both methods have
previously been shown to produce discrepant results,
which may be attributed to their different computational
approaches [24]. Our results deviate from the predicted
transition of myeloid phenotypes from the outer to the
inner rim and lesion center. Based on the myeloid states
defined by our marker panel, myeloid cells develop along
several independent fates, rather than one linear pheno-
type trajectory. We can however, not exclude that inclu-
sion of more or different activation markers may yield
different results.
The neighborhood analysis demonstrated distinct cel-
lular interaction signatures for both lesions, e.g. between
phagocytic inner rim macrophages and center astrocytes
in the early lesion, and between T cells and two myeloid
phenotypes in the late lesion. This indicates that cellular
interactions in this hypercellular lesion environment are
not random, but occur between specific subpopulations
and cell types such as lymphocytes. The low parametric
depth of our study does not allow us to identify the
functional implications of these interactions; however,
they may represent nodal points of cellular communica-
tion critical for lesion formation and maintenance of
low-grade inflammation.
Finally, spatial variance component analysis (SVCA)
suggests that cell-extrinsic factors drive marker expression
to a higher degree in the lesion rim than in the center.
Conversely, cell-intrinsic factors have a more prominent
influence on marker expression in the lesion center. This
suggests that glia cells in the lesion rim respond to cues
from the microenvironment, such as cytokines or
receptor-ligand interactions, while glial activation in the
lesion center is the result of cell-intrinsic programs set in
motion e.g. by myelin phagocytosis.
Myeloid cell/microglial heterogeneity has recently
been examined by us and others with single-cell RNA
sequencing in the healthy CNS, MS lesions, and other
neurological diseases such as Alzheimer’s disease,
Parkinson’s disease and temporal lobe epilepsy [22, 27].
These efforts have identified multiple myeloid cell/
microglial phenotypes, comparable with our results.
One of the microglia clusters, which was enriched for
genes associated with MS susceptibility and character-
ized by high expression of CD74, was also enriched for
genes that were highly expressed in our rim phenotypes
(m1 and 5), suggesting that the MS-related CD74+
phenotype corresponds to our rim myeloid phenotypes.
We confirmed this congruency by staining our MS
lesions with anti-CD74, which was expressed predom-
inantly by myeloid cells occupying the lesion rim
(Additional file 1: Figure S9). Other attempts to cluster
myeloid cells in experimental autoimmune encephalo-
myelitis (EAE), a mouse model of MS, using single-cell
cytometry [25], and in MS lesions using single nuclear
RNA sequencing [14], have yielded substantially less
myeloid cell heterogeneity.
Our study is limited by the small sample size and the
low number of markers, which may result in inaccurate
phenotype clustering. Moreover, we acknowledge that
no definite conclusions can be drawn from a comparison
of two lesions from different individuals. Nevertheless,
as a proof-of-concept study it demonstrates the ability of
multiplexed tissue imaging and appropriate single-cell
analytics to reveal the heterogeneity and spatial proper-
ties of glial cell phenotypes in MS lesions. Future appli-
cations may combine cell clustering based on single-
nucleus RNA sequencing data with highly multiplexed
imaging to obtain maximal parametric depth and spatial
resolution of phenotypes. This will help define the phe-
notypes and key interaction networks that drive acute
demyelination and chronic low-grade inflammation in
established lesions. This may ultimately provide novel tar-
gets for therapeutic intervention in relapsing-remitting
and progressive MS.
Conclusions
In summary, we found that phenotypic clustering
based on differential expression of thirteen glial acti-
vation markers produced multiple myeloid cell and
astrocyte phenotypes that occupied specific lesion
zones. Myeloid cells were activated along a rim-to-
center axis, and specific myeloid cell-astrocyte-
lymphocyte interactions were present in both lesions.
Our study highlights the potential of imaging mass
cytometry, paired with novel computational tools, to
provide insight into lesion-forming phenotypes and
their spatial organization in MS lesions.
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